WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
WuXi Biologics released its 2025 Sustainability Report, highlighting its commitment to advancing sustainable growth and improving healthcare access through technology and innovation. The company has made significant progress in enhancing governance transparency, empowering employees, and accelerating climate actions.
WuXi Biologics has released its 2025 Sustainability Report, outlining its efforts to drive sustainable growth and improve healthcare access. The company is guided by a comprehensive sustainability strategy and has established science-based ESG targets. WuXi Biologics has achieved ISO 20400 Sustainable Procurement certification and ISO 22301 Business Continuity Management System certification. The company has a diverse workforce representing 51 nationalities, with 54% of STEM positions held by female employees. In 2025, employees contributed over 12,000 volunteer hours in local communities. WuXi Biologics is committed to creating long-term value through its end-to-end Green CRDMO solutions and driving responsible practices across the value chain.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.